PARP Inhibitors in Oncology

-


Summary:

Since hitting the market in 2015, drugs that target poly (ADP-ribose) polymerase (PARP) have transformed the clinical management of cancers harboring BRCA-mutations. As more PARP inhibitors have been commercialized, drug developers are turning their attention towards broadening drug labels and exploring combination strategies. This report covers the management of PARP inhibitors in the US, Europe, and Asia, focusing on efficacy and safety comparisons for approved products, current and future indications, and research and development strategies.

                                                                       Get Free Sample Report:

                                                   PARP Inhibitors in Oncology | Market Research Report


Scope:

This report combines key opinion leader insight with in-house analyst expertise and research to provide an insight-rich look at PARP inhibitors in the US, Europe, and Asia. Components of the report include - 
- Overview of PARP Inhibitors in Oncology: Background, mechanism of action, and clinical development of PARP inhibitors.
- Epidemiology Analysis: Which current and future disease spaces are relevant to PARP inhibitors.
- Marketed PARP Inhibitors: How the currently approved PARP inhibitors compare.
- Pipeline Assessment in the 8MM: What are the pipeline PARP inhibitor products in development in oncology.
- Key Players: What companies are developing PARP inhibitors in oncology.
- Research and Development Strategies: How are PARP inhibitor clinical trials being designed, and what combination strategies are being explored in the US, Europe, and Asia.
- Pricing, Reimbursement, and Regulatory Strategies: What current and future challenges face PARP inhibitors from a payers perspective.

Reasons to buy:

- Develop business strategies by understanding the trends shaping and driving the PARP inhibitor market in the US, Europe, and Asia.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the portfolios of various competitors.
- Identify areas of unmet need within the PARP inhibitor market to help drive research and development towards future market opportunities.
- Gain insights to help plan and design your clinical trials.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
- Identify key pricing and reimbursement strategies.

                                                                       Browse Full Report:

                                                                     PARP Inhibitors in Oncology 



Location: Massachusetts, USA

Comments

Post a Comment

Popular posts from this blog

CVX – Tigris Offshore Oil Field Development – Gulf of Mexico - Project Profile

-
Image
Synopsis "CVX – Tigris Offshore Oil Field Development – Gulf of Mexico - Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. The "CVX – Tigris Offshore Oil Field Development – Gulf of Mexico - Project Profile" is part of Timetrics database of 82,000+ construction projects. Our database includes a 10+ year archive of completed projects, full coverage of all global projects with a value greater than $25 million and key contact details for project managers, owners, consultants, contractors and bidders. Summary Chevron Corporation (CVX) plans to undertake the construction of an offshore oil field platform in northwest Keathley Canyon, Gulf of Mexico, the US. The project involves the construction of a semi-submersible platform with a production ...
Read more

Varun Beverages Zimbabwe( VBZ ) – Harare Bottling Plant - Project Profile, zimbabwe

-
Image
Synopsis: " VBZ Harare Bottling Plant Zimbabwe - Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. Summary: Varun Beverages Zimbabwe Pvt Ltd (VBZ), a subsidiary of RKJ Group is undertaking the construction of a bottling plant in Harare, Zimbabwe. The project involves the construction of a bottling plant on 7.3ha of land comprising an 8,125m2 manufacturing facility and a 1,330m2 utility area. The plant will have a high-speed 600-bottles-per-minute production line and an ultra-modern 400-cans-per-minute filling line. It includes the construction of a production unit, a packaging unit, an administrative space, a distribution unit, parking and related facilities. On November 13, 2015, a groundbreaking ceremony held. Scope: The project involves the...
Read more

India Oilfield Services Market By Application, By Service Competition | Forecast & Opportunities, 2013 - 2027

-
Image
SUMMARY: India Oilfield Services Market By Application (Onshore & Offshore), By Service (Drilling Services, Mud Engineering, Wireline Services, Pressure Pumping Services & Others), Competition Forecast & Opportunities, 2013 - 2027 According to “India Oilfield Services Market By Application, By Service, Competition Forecast & Opportunities, 2013 - 2027” , oilfield services market is forecast to grow at a CAGR of over 7% by 2027 in India. Growth in the market is anticipated on account of growing demand for oil & gas, rising on-site demand and evolving technologies being used in oilfields.  West and East regions are expected to witness a faster growth due to the presence of larger oil fields and allocation of new blocks in both offshore and onshore sites. Moreover, rising foreign investments in Indian oil & gas sector and rising adoption of advanced technology is further expected to propel growth in India oilfield services market through 2027. Some of...
Read more